title: Letter by Bernstein et al regarding article, "reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.
authors.forename: Richard A
authors.initials: RA
authors.lastname: Bernstein
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Alberts
authors.forename: David A
authors.initials: DA
authors.lastname: Garcia
mesh_terms: D000925:Anticoagulants / Q000037:antagonists & inhibitors*; D000931:Antidotes / Q000494:pharmacology*; D001562:Benzimidazoles / Q000037:antagonists & inhibitors*; D001777:Blood Coagulation / Q000187:drug effects*; D001779:Blood Coagulation Factors / Q000494:pharmacology*; D006801:Humans; D008297:Male; D009025:Morpholines / Q000037:antagonists & inhibitors*; D013876:Thiophenes / Q000037:antagonists & inhibitors*; D015091:beta-Alanine / Q000031:analogs & derivatives*
chemical_list: D000925:Anticoagulants; D000931:Antidotes; D001562:Benzimidazoles; D001779:Blood Coagulation Factors; D009025:Morpholines; D013876:Thiophenes; D015091:beta-Alanine